H1B Report
Side-by-side comparison

Sage Therapeutics, Inc. vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Sage Therapeutics, Inc.
MARank #FEIN 27-4486580
Entity B
WIPRO LIMITED
NJRank #5FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricSage Therapeutics, Inc.WIPRO LIMITED
Total filings4671,022
Certified %82.61%91.54%
Denied %6.52%0.38%
Withdrawn %8.70%1.34%
Cert-withdrawn %2.17%6.74%
Rank#5
Active yearsFY2015–FY2025FY2010–FY2026
Worksite stateMANJ

Outcomes — Sage Therapeutics, Inc.

DOL case-status mix.

Outcome breakdown: Certified 82.6%, Cert-withdrawn 2.2%, Withdrawn 8.7%, Denied 6.5%
Outcome breakdown
OutcomeShare
Certified82.6%
Cert-withdrawn2.2%
Withdrawn8.7%
Denied6.5%
Certified82.6%
Cert-withdrawn2.2%
Withdrawn8.7%
Denied6.5%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.5%, Cert-withdrawn 6.7%, Withdrawn 1.3%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.5%
Cert-withdrawn6.7%
Withdrawn1.3%
Denied0.4%
Certified91.5%
Cert-withdrawn6.7%
Withdrawn1.3%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Sage Therapeutics, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20130
FY20140
FY20151
FY20160
FY20176
FY20187
FY20193
FY20201
FY20217
FY20222
FY20238
FY20249
FY20252
FY20260
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,018
FY20113,025
FY20126,933
FY20136,525
FY20148,008
FY201511,733
FY201610,233
FY20174,938
FY20186,036
FY20194,053
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,062

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Or browse the full sponsor index.